Literature DB >> 26474114

The Association Between Low Admission Peak Plasma Creatinine Concentration and In-Hospital Mortality in Patients Admitted to Intensive Care in Australia and New Zealand.

Andrew A Udy1, Carlos Scheinkestel, David Pilcher, Michael Bailey.   

Abstract

OBJECTIVE: To evaluate the independent association between low peak admission plasma creatinine concentrations and in-hospital mortality in patients requiring critical care in Australia and New Zealand.
DESIGN: Multicenter, binational, retrospective cohort study.
SETTING: Data were extracted from the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation adult patient database. PATIENTS: All available records for the period 2000 to 2013 were utilized. The following exclusion criteria were applied: all readmission episodes (within the same hospital stay), missing in-hospital mortality, admission post kidney transplantation, chronic renal replacement therapy (hemodialysis or peritoneal dialysis), and missing peak plasma creatinine concentration. Demographic, anthropometric, admission, illness severity, laboratory, and outcome data were then extracted. Patients were categorized on the basis of their peak (maximum) plasma creatinine concentration recorded in the first 24 hours of ICU admission. Illness severity-adjusted associations with in-hospital mortality relative to a reference category of 70-79 μmol/L were then determined using multivariate logistic regression.
INTERVENTIONS: Nil.
MEASUREMENTS AND MAIN RESULTS: Data pertaining to 1,250,449 admissions were available for the study period. Following exclusions, 1,045,718 patients were included. Regression analysis identified that peak plasma creatinine concentrations less than 60 μmol/L measured in the first 24 hours after ICU admission imply a steadily increasing adjusted in-hospital mortality risk. In cases where this value is markedly low (< 30 μmol/L), the adjusted odds of dying in-hospital is over two-fold higher than the reference category and exceeds the risk implied with elevated (≥ 180 μmol/L) values. This finding was also independent of anthropometric data.
CONCLUSIONS: In a large heterogenous cohort of critically ill patients, low admission peak plasma creatinine concentrations are independently associated with increased risk-adjusted in-hospital mortality. Further research should now focus on the potential mechanisms underpinning this finding, such as a low skeletal muscle mass and/or fluid overload.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26474114     DOI: 10.1097/CCM.0000000000001348

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Kianoush Kashani
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.

Authors:  Kianoush Kashani; Kumar Sarvottam; Naveen L Pereira; Erin F Barreto; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2018-01-17       Impact factor: 2.863

3.  The two sides of creatinine: both as bad as each other?

Authors:  Marlies Ostermann; Kianoush Kashani; Lui G Forni
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Actual Sarcopenia Reflects Poor Prognosis in Patients with Esophageal Cancer.

Authors:  Akihiro Watanabe; Taro Oshikiri; Ryuichiro Sawada; Hitoshi Harada; Naoki Urakawa; Hironobu Goto; Hiroshi Hasegawa; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Daisuke Makiura; Yoshihiro Kakeji
Journal:  Ann Surg Oncol       Date:  2022-02-15       Impact factor: 5.344

5.  Low Body Mass Index, Serum Creatinine, and Cause of Death in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Kashish Goel; Rajiv Gulati; Guy S Reeder; Ryan J Lennon; Bradley R Lewis; Atta Behfar; Gurpreet S Sandhu; Charanjit S Rihal; Mandeep Singh
Journal:  J Am Heart Assoc       Date:  2016-10-31       Impact factor: 5.501

6.  Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.

Authors:  Susanne Stads; Louise Schilder; S Azam Nurmohamed; Frank H Bosch; Ilse M Purmer; Sylvia S den Boer; Cynthia G Kleppe; Marc G Vervloet; Albertus Beishuizen; Armand R J Girbes; Pieter M Ter Wee; Diederik Gommers; A B Johan Groeneveld; Heleen M Oudemans-van Straaten
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

7.  Urinary creatinine excretion is related to short-term and long-term mortality in critically ill patients.

Authors:  Lara Hessels; Niels Koopmans; Antonio W Gomes Neto; Meint Volbeda; Jacqueline Koeze; Annemieke Oude Lansink-Hartgring; Stephan J Bakker; Heleen M Oudemans-van Straaten; Maarten W Nijsten
Journal:  Intensive Care Med       Date:  2018-09-07       Impact factor: 17.440

8.  Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients.

Authors:  Tianjiao Tang; Yan Zhuo; Lingling Xie; Haozhong Wang; Ming Yang
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

9.  Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients.

Authors:  Chenxi Ren; Hang Su; Jun Tao; Ying Xie; Xiaoyan Zhang; Qihao Guo
Journal:  Clin Interv Aging       Date:  2022-03-01       Impact factor: 4.458

10.  Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.

Authors:  Jing Sun; Hui Yang; Wentao Cai; Jingwei Zheng; Ningzhe Shen; Xinxin Yang; Bujian Pan; Weiteng Zhang; Xiaodong Chen; Xian Shen
Journal:  BMC Gastroenterol       Date:  2022-01-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.